Results 61 to 70 of about 22,419 (100)

The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis. [PDF]

Intern Med, 2023
Hasegawa E, Ito S, Kurosawa Y, Kobayashi D, Otani H, Abe A, Nakazono K, Murasawa A, Narita I, Ishikawa H.   +9 more
europepmc   +1 more source

Serum nitric oxide and peroxynitrite levels in adult sero-positive rheumatoid arthritis treated with disease modifying antirheumatic drugs: a preliminary report

, 2010
Marwan S.M. Al-Nimer, SAMIR ABDUL-HASSAN AL-OBAIDI, KHALID S. AL-DULAIMI   +2 more
openalex   +2 more sources

Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease‐modifying antirheumatic drugs have influenced the use of leflunomide [PDF]

, 2015
Ashley M. Hopkins, Agnès Vitry, Catherine O‘Doherty, Susanna Proudman, Michael D. Wiese   +4 more
openalex   +1 more source

Rituximab, Apremilast, and Upadacitinib as Selected Biosimilar and Targeted Synthetic Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action: Their Current Use in Slowing Down the Progression of Disease. [PDF]

J Clin Med
Kawczak P, Feszak IJ, Bączek T.
europepmc   +1 more source

Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine. [PDF]

Front Pharmacol, 2023
Mei L, Gao K, He X, Jakobsson PJ, Huang R.   +4 more
europepmc   +1 more source

Complications of invasive oral procedures in patients with immune-mediated inflammatory disorders treated with biological and conventional disease-modifying antirheumatic drugs or glucocorticoids: a scoping review of the literature. [PDF]

BMC Oral Health
Radoi L, Kadri M, Gosset M.
europepmc   +1 more source

Risk of Herpes Zoster in Individuals on Biologics, Disease-Modifying Antirheumatic Drugs, and/or Corticosteroids for Autoimmune Diseases: A Systematic Review and Meta-Analysis [PDF]

, 2016
Fawziah Marra, Elaine Ah‐Gi Lo, V. Y. Kalashnikov, Kathryn Richardson   +3 more
openalex   +1 more source

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database. [PDF]

Front Pharmacol
Xiong W, Li Y, Hu L, He G, Huang J.
europepmc   +1 more source

Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022. [PDF]

Arthritis Rheumatol
Yalamanchili P, Lee LY, Bushnell G, Mannion ML, Dave CV, Horton DB.   +5 more
europepmc   +1 more source

Letter to the Editor Regarding: "Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry". [PDF]

Rheumatol Ther
Liu Z, Tian M, Duan L.
europepmc   +1 more source